Skip to main content

Table 1 General profile of the MDR-TB patients notified between 2011 and 2013

From: Treatment outcome of multidrug-resistant tuberculosis in Japan – the first cross-sectional study of Japan tuberculosis surveillance data

Notification year

2011

2012

2013

2011–2013

 

n

%

n

%

n

%

n

%

Total

59

100.0

64

100.0

49

100.0

172

100.0

Sex

 Male

36

61.0

47

73.4

35

71.4

118

68.6

 Female

23

39.0

17

26.6

14

28.6

54

31.4

Country of birth

 Japan-born

46

78.0

45

70.3

31

63.3

122

70.9

 Foreign-born

12

20.3

15

23.4

16

32.7

43

25.0

 Unknown

1

1.7

4

6.3

2

4.1

7

4.1

Age groups

 0–14

0

0.0

0

0.0

0

0.0

0

0.0

 15–64

32

54.2

33

51.6

30

61.2

95

55.2

 65+

27

45.8

31

48.4

19

38.8

77

44.8

Treatment history

 New

37

62.7

42

65.6

33

67.3

112

65.1

 Retreatment

22

37.3

22

34.4

16

32.7

60

34.9

  1. MDR-TB Multidrug-resistant TB, New: patient receiving TB treatment for the first time, Retreatment: patient who has previously received anti-TB drugs for more than 1 month